Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.

Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P; Canadian Knee OA Study Group.

Osteoarthritis Cartilage. 2002 Jul;10(7):518-27.

2.

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.

Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N; Canadian Knee OA Study Group.

Osteoarthritis Cartilage. 2002 Jul;10(7):506-17.

3.

Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.

Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P.

Osteoarthritis Cartilage. 2005 Feb;13(2):111-9.

4.

Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial.

Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S.

J Bone Joint Surg Am. 2003 Jul;85-A(7):1197-203.

PMID:
12851342
5.
6.

Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.

Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV.

Knee. 2008 Aug;15(4):318-24. doi: 10.1016/j.knee.2008.02.012. Epub 2008 Apr 21.

PMID:
18430574
7.

The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.

Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R.

Osteoarthritis Cartilage. 2005 Feb;13(2):104-10.

8.

Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.

Waddell D, Rein A, Panarites C, Coleman PM, Weiss C.

Am J Manag Care. 2001 Oct;7(10):981-91.

9.
10.
11.
12.

The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.

Zietz PM, Selesnick H.

Arthroscopy. 2008 Apr;24(4):416-22. doi: 10.1016/j.arthro.2007.10.014.

PMID:
18375273
13.

Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.

Jüni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, Züllig M, Guetg R, Häuselmann HJ, Schwarz H, Theiler R, Ziswiler HR, Dieppe PA, Villiger PM, Egger M; Swiss Viscosupplementation Trial Group.

Arthritis Rheum. 2007 Nov;56(11):3610-9.

14.

Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain.

Hatoum HT, Fierlinger AL, Lin SJ, Altman RD.

J Med Econ. 2014 May;17(5):326-37. doi: 10.3111/13696998.2014.902843. Epub 2014 Mar 21.

PMID:
24625229
15.
16.

A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.

Grootendorst P, Marshall D, Pericak D, Bellamy N, Feeny D, Torrance GW.

J Rheumatol. 2007 Mar;34(3):534-42.

PMID:
17343301
17.

Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis.

Cochrane T, Davey RC, Matthes Edwards SM.

Health Technol Assess. 2005 Aug;9(31):iii-iv, ix-xi, 1-114.

18.

Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.

Conrozier T, Jerosch J, Beks P, Kemper F, Euller-Ziegler L, Bailleul F, Chevalier X.

Arch Orthop Trauma Surg. 2009 Mar;129(3):417-23. doi: 10.1007/s00402-008-0601-2. Epub 2008 Mar 26.

PMID:
18365224
20.

A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up.

Waddell DD, Cefalu CA, Bricker DC.

J Knee Surg. 2005 Jan;18(1):7-15.

PMID:
15742592

Supplemental Content

Support Center